ITUS is harnessing the body's immune system in the fight against cancer.

About

ITUS Corporation is developing a platform called Cchek™, a series of inexpensive non-invasive blood tests for the early detection of cancer.

CAR T therapeutics

ITUS is developing chimeric antigen receptor T-cell (CAR T) therapies which genetically engineer a patient's own immune cells to fight cancer.

Sign up for email Updates

Be The First to Receive Breaking News

Sign Up Now
Logo Itus

Latest News & Events

ITUS Corporation Announces Second Commercial Focus for Cchek™ will be Breast Cancer

Read More...

ITUS to Ring the NASDAQ Closing Bell on July 5th

Read More...

ITUS Accelerates Schedule for its CAR T Therapy and Provides Update

Read More...

Stock Data

View Investors Relations
Nasdaq: ITUS
Price
Change

Cancer of the Lung, Breast, Colon, Prostate, and Stomach are the five most prevalent cancers worldwide.